Trial Profile
Phase I trial of anti-tumour CD8+ cytotoxic T lymphocytes for the treatment of cancer.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 01 Nov 2011
Price :
$35
*
At a glance
- Drugs Cytotoxic T lymphocytes (Primary)
- Indications Cancer
- Focus Adverse reactions; Therapeutic Use
- 01 Nov 2011 New trial record